174 related articles for article (PubMed ID: 26922829)
1. Collectin CL-P1 utilizes C-reactive protein for complement activation.
Roy N; Ohtani K; Matsuda Y; Mori K; Hwang I; Suzuki Y; Inoue N; Wakamiya N
Biochim Biophys Acta; 2016 Jun; 1860(6):1118-28. PubMed ID: 26922829
[TBL] [Abstract][Full Text] [Related]
2. Three pentraxins C-reactive protein, serum amyloid p component and pentraxin 3 mediate complement activation using Collectin CL-P1.
Roy N; Ohtani K; Hidaka Y; Amano Y; Matsuda Y; Mori K; Hwang I; Inoue N; Wakamiya N
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):1-14. PubMed ID: 27864148
[TBL] [Abstract][Full Text] [Related]
3. The collectins CL-L1, CL-K1 and CL-P1, and their roles in complement and innate immunity.
Hansen SW; Ohtani K; Roy N; Wakamiya N
Immunobiology; 2016 Oct; 221(10):1058-67. PubMed ID: 27377710
[TBL] [Abstract][Full Text] [Related]
4. Lectin-like oxidized LDL receptor 1 is involved in CRP-mediated complement activation.
Fujita Y; Yamaguchi S; Kakino A; Iwamoto S; Yoshimoto R; Sawamura T
Clin Chem; 2011 Oct; 57(10):1398-405. PubMed ID: 21821723
[TBL] [Abstract][Full Text] [Related]
5. The membrane-type collectin CL-P1 is a scavenger receptor on vascular endothelial cells.
Ohtani K; Suzuki Y; Eda S; Kawai T; Kase T; Keshi H; Sakai Y; Fukuoh A; Sakamoto T; Itabe H; Suzutani T; Ogasawara M; Yoshida I; Wakamiya N
J Biol Chem; 2001 Nov; 276(47):44222-8. PubMed ID: 11564734
[TBL] [Abstract][Full Text] [Related]
6. Soluble Collectin-12 (CL-12) Is a Pattern Recognition Molecule Initiating Complement Activation via the Alternative Pathway.
Ma YJ; Hein E; Munthe-Fog L; Skjoedt MO; Bayarri-Olmos R; Romani L; Garred P
J Immunol; 2015 Oct; 195(7):3365-73. PubMed ID: 26290605
[TBL] [Abstract][Full Text] [Related]
7. Expression and tissue localization of collectin placenta 1 (CL-P1, SRCL) in human tissues.
Selman L; Skjodt K; Nielsen O; Floridon C; Holmskov U; Hansen S
Mol Immunol; 2008 Jun; 45(11):3278-88. PubMed ID: 18423602
[TBL] [Abstract][Full Text] [Related]
8. Scavenger receptor collectin placenta 1 (CL-P1) predominantly mediates zymosan phagocytosis by human vascular endothelial cells.
Jang S; Ohtani K; Fukuoh A; Yoshizaki T; Fukuda M; Motomura W; Mori K; Fukuzawa J; Kitamoto N; Yoshida I; Suzuki Y; Wakamiya N
J Biol Chem; 2009 Feb; 284(6):3956-65. PubMed ID: 19073604
[TBL] [Abstract][Full Text] [Related]
9. Haplotype analysis of the human collectin placenta 1 (hCL-P1) gene.
Ohmori H; Makita Y; Funamizu M; Chiba S; Ohtani K; Suzuki Y; Wakamiya N; Hata A
J Hum Genet; 2003; 48(2):82-5. PubMed ID: 12601552
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
Duvall MR; Hwang HY; Boackle RJ
Immunobiology; 2010 May; 215(5):395-405. PubMed ID: 19586684
[TBL] [Abstract][Full Text] [Related]
11. Collectins and collectin receptors in innate immunity.
Holmskov UL
APMIS Suppl; 2000; 100():1-59. PubMed ID: 11021254
[TBL] [Abstract][Full Text] [Related]
12. Heteromeric complexes of native collectin kidney 1 and collectin liver 1 are found in the circulation with MASPs and activate the complement system.
Henriksen ML; Brandt J; Andrieu JP; Nielsen C; Jensen PH; Holmskov U; Jorgensen TJ; Palarasah Y; Thielens NM; Hansen S
J Immunol; 2013 Dec; 191(12):6117-27. PubMed ID: 24174618
[TBL] [Abstract][Full Text] [Related]
13. Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation.
Inforzato A; Peri G; Doni A; Garlanda C; Mantovani A; Bastone A; Carpentieri A; Amoresano A; Pucci P; Roos A; Daha MR; Vincenti S; Gallo G; Carminati P; De Santis R; Salvatori G
Biochemistry; 2006 Sep; 45(38):11540-51. PubMed ID: 16981714
[TBL] [Abstract][Full Text] [Related]
14. Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions.
Ji SR; Wu Y; Potempa LA; Liang YH; Zhao J
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):935-41. PubMed ID: 16456095
[TBL] [Abstract][Full Text] [Related]
15. The induction of human CL-P1 expression in hypoxia/reoxygenation culture condition and rat CL-P1 after ischemic/reperfusion treatment.
Koyama S; Ohtani K; Fukuzawa J; Yao N; Fukuda M; Jang SJ; Hasebe N; Kikuchi K; Itabe H; Yoshida I; Suzuki Y; Wakamiya N
Biochim Biophys Acta; 2011 Sep; 1810(9):836-42. PubMed ID: 21723916
[TBL] [Abstract][Full Text] [Related]
16. Complement regulation in innate immunity and the acute-phase response: inhibition of mannan-binding lectin-initiated complement cytolysis by C-reactive protein (CRP).
Suankratay C; Mold C; Zhang Y; Potempa LA; Lint TF; Gewurz H
Clin Exp Immunol; 1998 Sep; 113(3):353-9. PubMed ID: 9737662
[TBL] [Abstract][Full Text] [Related]
17. Scavenger receptor CL-P1 mainly utilizes a collagen-like domain to uptake microbes and modified LDL.
Mori K; Ohtani K; Jang S; Kim Y; Hwang I; Roy N; Matsuda Y; Suzuki Y; Wakamiya N
Biochim Biophys Acta; 2014 Dec; 1840(12):3345-56. PubMed ID: 25199873
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the interaction between collectin 11 (CL-11, CL-K1) and nucleic acids.
Henriksen ML; Brandt J; Iyer SS; Thielens NM; Hansen S
Mol Immunol; 2013 Dec; 56(4):757-67. PubMed ID: 23954398
[TBL] [Abstract][Full Text] [Related]
19. Collectins, collectin receptors and the lectin pathway of complement activation.
Malhotra R; Lu J; Holmskov U; Sim RB
Clin Exp Immunol; 1994 Aug; 97 Suppl 2(Suppl 2):4-9. PubMed ID: 8070142
[TBL] [Abstract][Full Text] [Related]
20. Investigations on collectin liver 1.
Axelgaard E; Jensen L; Dyrlund TF; Nielsen HJ; Enghild JJ; Thiel S; Jensenius JC
J Biol Chem; 2013 Aug; 288(32):23407-20. PubMed ID: 23814060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
